Open access
1,062
Views
1
CrossRef citations to date
0
Altmetric
ISV Annual Congress SF – Short Report
A novel SARS-CoV-2 subunit vaccine engineered on an immune-activating platform technology
Edward J. QuinlanResearch and Development, OmniCyte LLC, Guilford, CT, USAView further author information
, Richard ChubetResearch and Development, OmniCyte LLC, Guilford, CT, USAView further author information
& Peter LeonardiResearch and Development, OmniCyte LLC, Guilford, CT, USACorrespondence[email protected]
https://orcid.org/0000-0002-6084-3603View further author information
Article: 2062971
|
Received 20 Jan 2022, Accepted 31 Mar 2022, Published online: 08 Jul 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.